U.S. authorities are warning healthcare entities of security flaws in certain Fresenius Kabi Agilia Connect Infusion Systems. U.S. government authorities have issued an advisory warning about remotely ...

Less than a year after putting down $240 million to acquire of Ivenix and its sensor- and software-backed infusion pump, Fresenius Kabi is recalling more than 1,500 of them. The recall affects only ...

FDA has upgraded Fresenius Kabi’s voluntary recall of certain Ivenix Large Volume Pump (LVP) primary administration sets to Class I after the company identified a manufacturing defect that could cause ...

In its second and third such notices this week, the FDA doled out its most serious label to a pair of recalls of devices used in medication delivery. The first and larger of the two recalls came from ...

Fresenius Kabi USA recalled 1,546 large infusion pumps in a Class I recall, the most serious type, because of a risk of leaking products entering the electrical system and shutting down the device.

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, announced ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the successful smart pump interoperability of its Ivenix Infusion System at Fort HealthCare, a regional health care provider in ...

The U.S. FDA has announced a class I recall of Iveninx large-volume infusion pumps made by Fresenius Kabi USA of Lake Zurich, Ill., due to a mechanical issue with fluid valve pins that could cause the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has announced a class 1 recall, indicating that continued use may cause serious injuries or death.

FRANKFURT (Reuters) – German healthcare supplier Fresenius and British engineering company Smiths Group have emerged as the final bidders for Pfizer’s infusion pumps business in a possible deal worth ...